A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus
Article in Scientific Reports (June 2021)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Scientific Reports (June 2021)
Book chapter (January 2020)
Article in Scientific Reports (June 2019)